SCNX

+ Watchlist + Portfolio

Scienture Holdings, Inc.

Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.18
52-Week Range: $0.13 – $2.60
Market Cap: $260.84K
P/E (TTM): —
EPS (TTM): -52.75
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.10
PEG Ratio: —
Return on Equity: -53.47%
Return on Assets: -8.93%
Gross Margin: 87.72%
Operating Margin: -785.63%
Profit Margin: 0.00%
Current Ratio: 3.04
Debt/Equity: 0.17
Total Debt: $10.69M
Free Cash Flow: $-7.61M
Revenue Growth: —
Earnings Growth: —
Enterprise Value: $165.53M

SCNX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$10.25M	$1.36M	$136.64K	$431.61K
Cost of Revenue	$4.73M	$1.31M	$130.64K	$100.13K
Gross Profit	$5.52M	$49.03K	$6.00K	$331.48K
Research & Development	$993.18K	$0.00	$2.24M	$1.96M
Selling, General & Admin	$6.57M	$4.35M	$12.05M	$14.52M
Operating Expenses	$7.56M	$4.45M	$14.71M	$16.58M
Operating Income	-$2.04M	-$4.40M	-$14.70M	-$16.24M
EBITDA	-$1.87M	-$6.29M	-$17.39M	-$38.93M
Pretax Income	-$2.40M	-$8.48M	-$18.78M	-$43.51M
Income Tax	—	$0.00	-$534.40K	-$1.99M
Net Income	-$3.47M	-$17.84M	$9.07M	-$41.51M
Diluted EPS	-6.15	-23.35	2.48	-2.70
Diluted Shares	564863	2.38M	3.65M	15.35M

SCNX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$1.09M	$314.00	$308.10K	$6.66M
Receivables	$629.92K	$2.52M	$5.45M	$731.33K
Inventory	$65.52K	$968.00	$0.00	$213.41K
Current Assets	$2.09M	$2.75M	$6.31M	$7.92M
Total Assets	$3.71M	$12.53M	$104.85M	$84.18M
Current Liabilities	$2.15M	$11.56M	$7.91M	$2.74M
Long-Term Debt	$333.33K	$25.00K	$612.27K	—
Total Debt	$1.58M	$209.50K	$3.53M	$24.14K
Total Liabilities	$3.37M	$11.99M	$25.78M	$14.06M
Retained Earnings	-$19.72M	-$33.25M	-$39.04M	-$80.55M
Shareholders' Equity	$763.14K	$542.35K	$79.07M	$70.12M
Working Capital	-$53.67K	-$8.80M	-$1.60M	$5.18M
Net Debt	—	$6.40M	$3.00M	—

SCNX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$1.56M	-$2.23M	-$14.27M	-$13.38M
Capital Expenditure	-$450.85K	—	-$12.00K	—
Free Cash Flow	-$1.56M	-$2.23M	-$14.28M	-$13.38M
Depreciation & Amortisation	$194.70K	$1.05M	$53.36K	$491.78K
Stock-Based Compensation	$254.11K	$257.77K	$25.58K	$2.07M
Investing Cash Flow	-$427.85K	-$275.72K	$27.55M	$0.00
Financing Cash Flow	-$35.17K	$1.41M	-$12.98M	$19.73M
Dividends Paid	—	$0.00	-$14.86M	$0.00
Net Change in Cash	-$2.03M	-$1.09M	$307.78K	$6.35M

SCNX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$10.26K	$0.00	$590.05K	-$168.70K	$56.33K	$343.64K
Cost of Revenue	$9.59K	$0.00	$15.43K	$75.11K	$2.48K	$7.86K
Gross Profit	$673.00	$0.00	$574.62K	-$243.81K	$53.85K	$335.78K
Research & Development	$574.68K	$843.55K	$169.34K	$368.70K	$793.98K	$1.17M
Selling, General & Admin	$2.94M	$4.29M	$4.76M	$2.54M	$2.75M	$1.86M
Operating Expenses	$3.57M	$5.16M	$4.94M	$2.91M	$3.56M	$3.04M
Operating Income	-$3.57M	-$5.16M	-$4.36M	-$3.15M	-$3.51M	-$2.70M
EBITDA	-$2.38M	-$6.05M	-$1.80M	-$28.71M	-$2.90M	-$2.09M
Pretax Income	-$3.06M	-$6.72M	-$3.61M	-$30.12M	-$3.40M	-$2.82M
Income Tax	$0.00	$0.00	$0.00	-$1.99M	$0.00	$0.00
Net Income	-$3.06M	-$6.72M	-$3.61M	-$28.12M	-$3.40M	-$2.82M
Diluted EPS	-0.33	-0.48	-0.19	—	-0.08	-0.07
Diluted Shares	9.43M	14.14M	18.96M	—	40.63M	39.62M

SCNX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$2.05M	$15.39K	$355.69K	$6.66M	$3.54M	$8.19M
Receivables	$5.35M	$0.00	$590.05K	$731.33K	$722.54K	$385.31K
Inventory	—	—	$234.52K	$213.41K	$210.93K	$203.07K
Current Assets	$7.83M	$856.63K	$1.42M	$7.92M	$4.77M	$9.20M
Total Assets	$106.36M	$104.29M	$104.83M	$84.18M	$80.66M	$87.73M
Current Liabilities	$7.46M	$7.69M	$7.35M	$2.74M	$2.80M	$3.03M
Long-Term Debt	$1.09M	$1.58M	—	—	—	$9.57M
Total Debt	$3.81M	$4.12M	$2.56M	$24.14K	$10.00K	$10.69M
Total Liabilities	$25.20M	$26.43M	$22.16M	$14.06M	$13.84M	$23.63M
Retained Earnings	-$42.10M	-$48.82M	-$52.43M	-$80.55M	-$83.95M	-$86.78M
Shareholders' Equity	$81.16M	$77.86M	$82.67M	$70.12M	$66.82M	$64.10M
Working Capital	$363.56K	-$6.83M	-$5.93M	$5.18M	$1.97M	$6.18M
Net Debt	$1.56M	$4.08M	$2.18M	—	—	$2.50M

SCNX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$2.96M	-$7.02M	$1.78M	-$5.18M	-$2.92M	-$9.18M
Free Cash Flow	-$2.96M	-$7.02M	$1.78M	-$5.18M	-$2.92M	-$9.18M
Depreciation & Amortisation	$15.02K	$15.46K	$6.95K	$454.35K	$468.01K	$461.57K
Stock-Based Compensation	—	—	$1.66M	$248.46K	—	—
Investing Cash Flow	$0.00	$0.00	$0.00	$0.00	—	—
Financing Cash Flow	$4.70M	$0.00	$3.55M	$11.48M	-$200.00K	$10.79M
Dividends Paid	$0.00	$0.00	$0.00	$0.00	—	—
Net Change in Cash	$1.74M	-$2.03M	$340.30K	$6.31M	-$3.12M	$7.66M

Market Snapshot

About

Scienture Holdings, Inc. is a holding company that operates through its subsidiaries in the healthcare technology sector. The company focuses on developing and commercializing innovative solutions for medical diagnostics and treatment applications.